First-line immune defences against COVID-19 are short-lived and may explain reinfection
A new study finds that antibodies produced in the nose decline nine months after COVID-19 infection, while antibodies found in ...
Tag: Firstline
First-line ribociclib plus endocrine therapy may be more effective than combination chemotherapy in patients with aggressive breast cancer
SAN ANTONIO – In patients with hormone receptor-positive, HER2-negative, advanced breast cancer— including patients with visceral crises—those treated with ribociclib ...
First-line pembrolizumab or placebo combined with etoposide and platinum for ES-SCLC: KEYNOTE-604 Long-Term
First-Line Pembrolizumab or Placebo Combined With Etoposide and Platinum for ES-SCLC: KEYNOTE-604 Long-Term (Vienna—August 9, 2022, 10:10 a.m. CEST)—Long -term ...
First-line CDK 4/6 inhibition shows overall survival benefit for metastatic breast cancer
Lugano, Switzerland, 19 September 2021 – Adding a CDK 4/6 inhibitor to first-line hormonal treatment prolongs survival by one year for postmenopausal women with hormone receptor (HR) positive, HER2 negative ...
-
Groundbreaking mathematical proof: new insights into typhoon dynamics unveiled
-
New study will examine irritable bowel syndrome as long COVID symptom
-
Null results research now published by major behavioral medicine journal
-
Weather researchers explore deep convective clouds in coastal cities
-
A better understanding of myalgic encephalomyelitis/chronic fatigue syndrome could benefit long COVID patients
-
Hairy polymer balls help get genetic blueprints inside T-cells for blood cancer therapy